1Mori T, Aisa Y, Yokoyama A, et al. Total body irradiation and granulocyte colony-stimulating factor-combined high-dose cytarabine as a conditioning regimen in allogeneic hematopoietic stem cell transplantation for advanced myelodysplastic syndrome: a single-institute experience. Bone Marrow Transplant, 2007 Feb;39(4) :217-221.
2Berthold F, Boos J, Burdach S, et al. Myeloablative megatherapy with autologous stem-cell rescue versus oral maintenance chemotherapy as consolidation treatment in patients with high-risk neuroblastoma : a randomised controlled trial. Lancet Oncol, 2005 Sep ;6 (9) : 649-658.
3Matthay KK, Villablanca JG, Seeger RC, et al. Treatment of highrisk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group. N Engl J Med, 1999;341:1165-1173.
4Kletzel M, Abella EM, Sandier ES, et al. Thiotepa and cyclophosphamide with stem cell rescue for consolidation therapy for children with high-risk neuroblastoma : a phase I /Ⅱ study of the Pediatric Blood and Marrow Transplant Consortium. J Pediatr Hematol Oncol, 1998 Jan-Feb;20( 1 ) :49-54.
5Marcus K J, Shamberger R, Litman H, et al. Primary tumor control in patients with stage 3/4 unfavorable neuroblastoma treated with tandem double autologous stem cell transplants. J Pediatr Hematol Oncol, 2003 Dec;25(12) :934-940.
6Grupp SA, Stem JW, Bunin N, et al. Tandem high-dose therapy in rapid sequence for children with high-risk neuroblastoma. J Clin Oncol, 2000 Jul; 18( 1 3) :2567-2575.
7George RE, Li S, Medeiros-Nancarrow C, et al. High-Risk Neuroblastoma Treated With Tandem Autologous Peripheral-Blood Stem Cell-Supported Transplantation: Long-Term Survival Update. J Clin Oncol, 2006 Jun 20 ;24 ( 18 ) :2891-2896.
8Tchirkov A, Kanold J, Giolant M, et al. Molecular monitoring of tumor cell contamination in lexrkapheresis products from stage IV neuvoblastoma patients before and after positive CD34^+ selection. MedPediatr Oneol, 1998 ;30(4) : 228-232.
9Handgretinger R, Lang P, Ibm K, et al. Isolation and transplantation of highly purified autologous peripheral CD34^+ progenitor cells : purging efficacy, hematopoietic reconstitution and long-term outcome in children with high-risk neuroblastoma. Bone Marrow Transplant, 2002;29(9) : 731-736.
10Ryu KH, Ahu HS, Koo HH, et al. Autologous stem cell transplantation for the treatment of neuroblastoma in Korea. J Korean Med Sci, 2003 ; 18:242-247.
4Du C, Fang M, Li Y, et al. Smac, a mitochondrial protein that promotes cytochrome c - dependent caspase activation by eliminating IAP inhibition [ J ]. Cell ,2000,102 ( 1 ) : 33 - 42.
5Mohr A, Buneker C, Gough RP, et al. MnSOD protects colorectal cancer cells from TRAIL - induced apoptosis by inhibition of Smac/DIABLO release [J]. Oncogene,2008,27 (6) : 763 - 774.
6Nieminen AI, Partanen JI, Klefstrom J. c - Myc blazing a trail of death : Coupling of the mitochondrial and death receptor apoptosis pathways by c - Myc[ J]. Cell Cycle,2007,6(20) :2464 -2472.
7Kendrick JE, Estes JM, Straughn JM,Jr, et al. Tumor necrosis factor - related apoptosis- inducing ligand (TRAIL) and its therapeutic potential in breast and gynecologic cancers [ J ]. Gynecol Oncol, 2007, 106 (3) :614 -621.
8Thorburn A. Tumor necrosis factor - related apoptosis - inducing ligand (TRAIL) pathway signaling[J]. J Thorac Oncol,2007,2(6) :461 -465.
9Ferguson TA, Griffith TS. The role of Fas ligand and TNF - related apoptosis- inducing ligand (TRAIL) in the ocular immune response [ J ]. Chem Immunol Allergy,2007,92 ( 1 ) : 140 - 154.
10Chaudhari BR, Murphy RF, Agrawal DK. Following the TRAIL to apoptosis [ J ]. Immunol Res,2006, 35 ( 3 ) :249 - 262.
